| |
| |
|
| Insider
Information: |
Knopf John L |
| Relationship: |
CEO and President, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
214,084 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,267,515 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
214,084 |
|
|
| Total
Value |
$38,267,515 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
CEO and President, Dir... |
2016-11-09 |
214,084 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
CEO and PresidentOfficer |
• • – |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
221,500 |
|
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-05-19 |
4 |
AS |
$31.49 |
$472,726 |
D/D |
(15,000) |
206,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-06-09 |
4 |
AS |
$31.14 |
$474,722 |
D/D |
(15,000) |
191,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-07-07 |
4 |
AS |
$31.42 |
$555,427 |
D/D |
(17,500) |
174,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-08-14 |
4 |
AS |
$29.78 |
$521,150 |
D/D |
(17,500) |
156,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-09-08 |
4 |
AS |
$24.91 |
$166,931 |
D/D |
(6,700) |
149,800 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-09-09 |
4 |
AS |
$24.21 |
$322,230 |
D/D |
(13,300) |
136,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-10-07 |
4 |
AS |
$29.22 |
$292,200 |
D/D |
(10,000) |
126,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-10-08 |
4 |
AS |
$30.20 |
$302,000 |
D/D |
(10,000) |
116,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-11-12 |
4 |
AS |
$32.57 |
$660,799 |
D/D |
(20,000) |
96,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2014-12-08 |
4 |
AS |
$38.43 |
$879,886 |
D/D |
(20,000) |
76,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-01-07 |
4 |
AS |
$38.93 |
$792,324 |
D/D |
(20,000) |
56,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-01-21 |
4 |
OE |
$0.40 |
$5,000 |
D/D |
12,500 |
69,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-01-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,416 |
67,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-02-09 |
4 |
AS |
$36.59 |
$732,982 |
D/D |
(20,000) |
47,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-03-09 |
4 |
AS |
$40.15 |
$804,951 |
D/D |
(20,000) |
27,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-04-07 |
4 |
OE |
$3.88 |
$19,400 |
D/D |
5,000 |
17,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-04-07 |
4 |
AS |
$34.75 |
$697,484 |
D/D |
(20,000) |
12,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-06-08 |
4 |
AS |
$32.50 |
$617,764 |
D/D |
(19,000) |
17,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-06-08 |
4 |
OE |
$3.88 |
$73,720 |
D/D |
19,000 |
36,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-07-07 |
4 |
OE |
$3.88 |
$77,760 |
D/D |
19,000 |
36,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-07-07 |
4 |
AS |
$29.66 |
$564,366 |
D/D |
(19,000) |
17,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-07-30 |
4 |
OE |
$0.40 |
$1,600 |
D/D |
4,000 |
21,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-08-10 |
4 |
AS |
$28.51 |
$542,045 |
D/D |
(19,000) |
21,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-08-10 |
4 |
OE |
$5.08 |
$96,520 |
D/D |
19,000 |
40,584 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
